MGIM
TBIO

M&G Investment Management’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

M&G Investment Management’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-52,593
Closed -$947 – 493
2020
Q4 		$947 Buy
+52,593
New +$941K 0.01% 332

Other funds holding TBIO

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AVA
Atlas Venture Advisors Boston, Massachusetts $143M AUM 25.68% 1-Year Est. Return

M&G Investment Management's TBIO Position: Q1 2021 in Review

M&G Investment Management sold out of Translate Bio, Inc. Common Stock (TBIO) in Q1 2021, closing a stake of 52,593 shares — an estimated $947 sold.

M&G Investment Management first reported a position in TBIO in Q4 2020 and held it in 1 quarter. The position peaked at $947 in Q4 2020. 146 funds tracked by Wall St. Rank hold TBIO as of Q1 2021.

  • M&G Investment Management reported no remaining Translate Bio, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • M&G Investment Management sold 52,593 Translate Bio, Inc. Common Stock shares in Q1 2021, an estimated $947.
  • M&G Investment Management first reported a position in Translate Bio, Inc. Common Stock in Q4 2020 and held it in 1 quarter.
  • M&G Investment Management's Translate Bio, Inc. Common Stock position peaked at $947 in Q4 2020.
  • 146 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q1 2021.

Based on M&G Investment Management's 13F filing for Q1 2021, filed 12 May 2021.